PursueCare RESET 2.0.2
PursueCare RESET 2.0.2 is a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Substance Use Disorders) made by Harvest Bio LLC, granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 28 Apr 2025 (UDI-DI 00850074433002), active as of 22 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00850074433002 | Date28 Apr 2025 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN160018 | Date14 Sep 2017 | StatusActive |
Official records
- AccessGUDID record 00850074433002
- FDA De Novo database DEN160018
From the FDA record
- Device description
- RESET Mobile Application runs on iOS and is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN160018 decided 14 Sep 2017 Active
- FDA GUDID UDI-DI 00850074433002 listed 28 Apr 2025 Listed
Timeline
- Granted FDA De Novo DEN160018
- Listed FDA GUDID 00850074433002
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- PursueCare RESET
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- 2.0.2
- Primary DI / UDI-DI
- 00850074433002
- De Novo Number
- FDA product code
- PWE
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution